Blueline Bioscience partners with Celgene to advance early-stage life sciences
Blueline Bioscience, a Toronto-based biotech incubator launched earlier this year by U.S. venture capital firm Versant Ventures, has entered into a new partnership with Celgene Corp, a manufacturer of drug therapies for cancer and inflammatory disorders with headquarters in Summit, New Jersey. Under the terms of the collaboration, Celegene will have certain option rights with respect to early-stage life sciences companies launched by the incubator in such fields as oncology and inflammation. Versant Ventures recently established an office in Vancouver. Blueline Bioscience is located in the MaRS Discovery District.
20 November 2013•3 mins read
